<?xml version="1.0" encoding="UTF-8"?>
<p>Most studies published have not shown a benefit when corticosteroids are used in coronavirus infections. In fact, the use of methylprednisolone as an intervention for SARS patients was associated with a higher 30-day mortality rate [
 <xref ref-type="bibr" rid="CR1">1</xref>]. A randomized, placebo-controlled study of SARS patients suggested that those given steroids early in the infection developed prolonged viremia. Finally, patients with MERS who were treated with methylprednisolone, with or without antiviral agents or interferons, showed no improved outcomes [
 <xref ref-type="bibr" rid="CR1">1</xref>].
</p>
